Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Princen, F.
Right arrow Articles by Bours, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Princen, F.
Right arrow Articles by Bours, V.
Clinical Cancer Research Vol. 5, 3639-3644, November 1999
© 1999 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

A Cell Type-specific and Gap Junction-independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-mediated Bystander Effect1

Frédéric Princen, Pierre Robe, Chantal Lechanteur, Marc Mesnil, Jean-Michel Rigo, Jacques Gielen, Marie-Paule Merville and Vincent Bours2

Laboratory of Medical Chemistry and Medical Oncology [F. P., C. L., J. G., M-P. M., V. B.] and Departments of Human Physiology [P. R., J-M. R.] and Neurosurgery [P. R.], University of Liège, 4000 Liège, Belgium, and Unit of Multistage Carcinogenesis, IARC, 69372 Lyon, France [M. M.]

Tumor cells expressing the herpes simplex virus type 1 thymidine kinase (HSV-tk) gene are killed by nucleoside analogues such as ganciclovir (GCV). GCV affects not only the cells expressing HSV-tk but also neighboring cells that do not express the gene; this phenomenon commonly is called "bystander effect." GCV metabolites transfer via gap junctional intercellular communication (GJIC) accounts for the bystander effect in different cell lines, but other mechanisms have also been described. In this study, we analyzed the mechanisms of the bystander effect in two cell lines exhibiting different capacities of communication (DHD/K12 and 9L). The 9L cells exhibited a very good bystander effect, which was completely blocked by a long-term inhibitor of GJIC, 18 {alpha}-glycyrrhetinic acid. DHD/K12 cells exhibited a moderate bystander effect that was not abolished by 18 {alpha}-glycyrrhetinic acid or 1-octanol, another strong inhibitor of GJIC. Interestingly, we also observed a bystander effect in cultures where HSV-tk-expressing DHD/K12 cells were physically separated from their untransfected counterparts but grown in the same medium. Moreover, the transfer of filtered conditioned medium from GCV-treated HSV-tk-expressing DHD/K12 cells to DHD/K12 parental cells induced a decrease of survival in a concentration-dependent manner, suggesting that the bystander effect in this cell line was mediated by a soluble factor.




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
M. Ahtiainen, J. Toppari, M. Poutanen, and I. Huhtaniemi
Indirect Sertoli Cell-Mediated Ablation of Germ Cells in Mice Expressing the Inhibin-{alpha} Promoter/Herpes Simplex Virus Thymidine Kinase Transgene
Biol Reprod, November 1, 2004; 71(5): 1545 - 1550.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
R. Thust, M.T. Tomicic, R. Grabner, C. Friedrichs, P. Wutzler, and B. Kaina
Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells
Mutagenesis, January 1, 2004; 19(1): 27 - 33.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Zhou, M. Suzuki, G. Randers-Pehrson, D. Vannais, G. Chen, J. E. Trosko, C. A. Waldren, and T. K. Hei
Radiation risk to low fluences of alpha particles may be greater than we thought
PNAS, December 4, 2001; 98(25): 14410 - 14415.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Niu, K. H. Shain, M. Huang, R. Ravi, A. Bedi, W. S. Dalton, R. Jove, and H. Yu
Overexpression of a Dominant-Negative Signal Transducer and Activator of Transcription 3 Variant in Tumor Cells Leads to Production of SolubleFactors That Induce Apoptosis and Cell Cycle Arrest
Cancer Res., April 1, 2001; 61(8): 3276 - 3280.
[Abstract] [Full Text]


Home page
BloodHome page
M. I. Garin, E. Garrett, P. Tiberghien, J. F. Apperley, D. Chalmers, J. V. Melo, and C. Ferrand
Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene
Blood, January 1, 2001; 97(1): 122 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Mesnil and H. Yamasaki
Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1
Cancer Res., August 1, 2000; 60(15): 3989 - 3999.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.